The likely mechanism involves PI3K inhibition targeting immune suppressor cells to reeducate the tumor immune microenvironment and restore cytotoxic T cell activity (Ahmad et al., 2017; De Henau et al., 2016; Kaneda et al., 2016b; Sai et al., 2017). Here, PIK3CG is linked to neoplasm.